Multikinase inhibitors

GS LHF 75 mg Pill - pink capsule-shape

Generic Name: dabrafenib

Pill with imprint GS LHF 75 mg is Pink, Capsule-shape and has been identified as Tafinlar 75 mg. It is supplied by GlaxoSmithKline.

Tafinlar is used in the treatment of Thyroid Cancer; Melanoma, Metastatic; Non-Small Cell Lung Cancer; Low-Grade Glioma; Solid Tumors and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tafinlar 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Tafinlar (Dabrafenib [ da-braf-e-nib ])-GS LHF 75 mg-75 mg-Pink-Capsule-shape

Tafinlar
Generic Name: dabrafenib [ da-braf-e-nib ]
Imprint: GS LHF 75 mg
Strength: 75 mg
Color: Pink
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Multikinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Silicon dioxide, Magnesium stearate, Microcrystalline cellulose, Hypromelloses, Ferric oxide red, Titanium dioxide,
Latest News
Related Drugs